Health Trials

Borderline Resectable/Unresectable Pancreatic Cancer

1

Review clinical trials related to Borderline Resectable/Unresectable Pancreatic Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

By doing this study, it is the hope to learn whether an injection of the measles, mumps, rubella (MMR) vaccine developed by Merck \& Co. (Merck's M-M-R® II) into the tumor is safe and effective in making the tumor smaller.

Participants needed: 20
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of ArkansasUpdated: Jun 10, 2026
Eligibility criteria

Age ≥ 18 years. [+11]

Pancreatic cancer that was either resectable before SoC treatment or became rese... [+6]

Read more